Trial Profile
An open label, pharmacokinetics study to evaluate the micafungin in infants supported with extracorporeal membrane oxygenation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Candidiasis
- Focus Pharmacokinetics
- 14 Sep 2015 New trial record